The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants
- 1 November 1990
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 163 (5) , 1474-1479
- https://doi.org/10.1016/0002-9378(90)90608-a
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women.BMJ, 1988
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacementAmerican Journal of Obstetrics and Gynecology, 1985
- The use of hormone implants for climacteric symptomsAmerican Journal of Obstetrics and Gynecology, 1984
- HORMONAL PROFILES IN POSTMENOPAUSAL WOMEN AFTER THERAPY WITH SUBCUTANEOUS IMPLANTSBJOG: An International Journal of Obstetrics and Gynaecology, 1981
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981
- Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal femalesEuropean Journal of Clinical Investigation, 1980
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976
- POSTMENOPAUSAL OSTEOPOROSISJAMA, 1941